A detailed history of Reynders Mc Veigh Capital Management, LLC transactions in Danaher Corp stock. As of the latest transaction made, Reynders Mc Veigh Capital Management, LLC holds 222,995 shares of DHR stock, worth $51.1 Million. This represents 3.29% of its overall portfolio holdings.

Number of Shares
222,995
Previous 222,318 0.3%
Holding current value
$51.1 Million
Previous $55.5 Million 11.61%
% of portfolio
3.29%
Previous 3.16%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$239.25 - $280.76 $161,972 - $190,074
677 Added 0.3%
222,995 $62 Million
Q2 2024

Aug 13, 2024

BUY
$235.51 - $267.98 $655,424 - $745,788
2,783 Added 1.27%
222,318 $55.5 Million
Q1 2024

May 07, 2024

BUY
$224.58 - $256.19 $520,351 - $593,592
2,317 Added 1.07%
219,535 $54.8 Million
Q4 2023

Feb 07, 2024

SELL
$185.1 - $233.13 $268,765 - $338,504
-1,452 Reduced 0.66%
217,218 $50.3 Million
Q3 2023

Nov 09, 2023

SELL
$233.08 - $265.59 $184,599 - $210,347
-792 Reduced 0.36%
218,670 $54.3 Million
Q2 2023

Aug 09, 2023

SELL
$224.99 - $256.14 $224 - $256
-1 Reduced -0.0%
219,462 $52.7 Million
Q1 2023

May 03, 2023

SELL
$239.75 - $277.0 $1.3 Million - $1.5 Million
-5,413 Reduced 2.41%
219,463 $55.3 Million
Q4 2022

Feb 10, 2023

SELL
$241.42 - $282.29 $1.05 Million - $1.22 Million
-4,329 Reduced 1.89%
224,876 $59.7 Million
Q3 2022

Nov 08, 2022

BUY
$247.06 - $1507.4 $34,094 - $208,021
138 Added 0.06%
229,205 $59.2 Million
Q2 2022

Aug 05, 2022

SELL
$237.11 - $299.66 $287,140 - $362,888
-1,211 Reduced 0.53%
229,067 $58.1 Million
Q1 2022

May 11, 2022

SELL
$257.27 - $315.76 $232,829 - $285,762
-905 Reduced 0.39%
230,278 $67.5 Million
Q4 2021

Feb 11, 2022

SELL
$292.08 - $329.01 $458,857 - $516,874
-1,571 Reduced 0.67%
231,183 $76.1 Million
Q3 2021

Nov 15, 2021

SELL
$272.21 - $332.43 $440,980 - $538,536
-1,620 Reduced 0.69%
232,754 $70.9 Million
Q2 2021

Aug 12, 2021

SELL
$225.08 - $271.69 $540,642 - $652,599
-2,402 Reduced 1.01%
234,374 $62.9 Million
Q1 2021

May 07, 2021

SELL
$212.38 - $245.9 $178,823 - $207,047
-842 Reduced 0.35%
236,776 $53.3 Million
Q4 2020

Feb 10, 2021

SELL
$212.5 - $245.46 $347,437 - $401,327
-1,635 Reduced 0.68%
237,618 $52.8 Million
Q3 2020

Oct 28, 2020

SELL
$177.16 - $215.33 $294,971 - $358,524
-1,665 Reduced 0.69%
239,253 $51.5 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $23,680 - $32,536
-184 Reduced 0.08%
240,918 $42.6 Million
Q1 2020

May 13, 2020

BUY
$121.39 - $169.05 $666,188 - $927,746
5,488 Added 2.33%
241,102 $33.4 Million
Q4 2019

Feb 14, 2020

SELL
$133.47 - $153.48 $212,350 - $244,186
-1,591 Reduced 0.67%
235,614 $36.2 Million
Q3 2019

Nov 08, 2019

BUY
$135.4 - $146.47 $160,855 - $174,006
1,188 Added 0.5%
237,205 $34.3 Million
Q2 2019

Aug 06, 2019

SELL
$124.88 - $143.73 $891,018 - $1.03 Million
-7,135 Reduced 2.93%
236,017 $33.7 Million
Q1 2019

May 10, 2019

BUY
$97.62 - $132.29 $636,384 - $862,398
6,519 Added 2.75%
243,152 $32.1 Million
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $1.09 Million - $1.26 Million
11,465 Added 5.09%
236,633 $24.4 Million
Q3 2018

Nov 26, 2018

BUY
$98.13 - $108.9 $353,268 - $392,040
3,600 Added 1.62%
225,168 $24.5 Million
Q2 2018

Aug 09, 2018

SELL
$96.1 - $103.24 $47,665 - $51,207
-496 Reduced 0.22%
221,568 $21.9 Million
Q1 2018

Jul 26, 2018

BUY
$92.16 - $103.8 $18.5 Million - $20.8 Million
200,322 Added 921.36%
222,064 $21.7 Million
Q1 2018

May 03, 2018

SELL
$92.16 - $103.8 $16.5 Million - $18.5 Million
-178,667 Reduced 89.15%
21,742 $222 Million
Q4 2017

Feb 06, 2018

BUY
$85.26 - $94.62 $606,710 - $673,315
7,116 Added 3.68%
200,409 $0
Q3 2017

Nov 09, 2017

BUY
$79.29 - $88.45 $1.16 Million - $1.3 Million
14,675 Added 8.22%
193,293 $16.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
178,618
178,618 $15.1 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Reynders Mc Veigh Capital Management, LLC Portfolio

Follow Reynders Mc Veigh Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reynders Mc Veigh Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reynders Mc Veigh Capital Management, LLC with notifications on news.